1. Mahmood KT, Tahir FA, Haq IU. Pharmacovigilance: a need for best patient care in Pakistan: a review. J Pharm Sci Res. 2011; 3:1566–1584.
2. Iffat W, Shakeel S, Naseem S, Imam S, Khan M. Attitudinal survey to assess medical and dental students’ belief of ADR reporting in Pakistan. Int J Pharm Pharm Sci. 2014; 6:279–283.
3. Ahmad A, Patel I, Balkrishnan R, Mohanta GP, Manna PK. An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: a pilot study. PerspectClin Res. 2013; 4:204–210.
http://dx.doi.org/10.4103/2229-3485.120168.
Article
4. Elkalmi RM, Hassali MA, Ibrahim MI, Widodo RT, Efan QM, Hadi MA. Pharmacy students’ knowledge and perceptions about pharmacovigilance in Malaysian public universities. Am J Pharm Educ. 2011; 75:96.
http://dx.doi.org/10.5688/ajpe75596.
Article
5. Sathvik BS, Chukir DM, Abo-Aldan E, Soliman MN. Adverse drug reaction monitoring and reporting: knowledge, attitude and belief of physicians & pharmacists of Aas al Khaimah, United Arab Emirates (UAE). Int J Pharm Sci Res. 2014; 5:368–375.
http://dx.doi.org/10.13040/IJPSR.0975-8232.5(2).368-75.
6. Li Q, Zhang SM, Chen HT, Fang SP, Yu X, Liu D, Shi LY, Zeng FD. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chin Med J (Engl). 2004; 117:856–861.
7. Mann RD, Andrews EB. Pharmacovigilance. 2nd ed. West Sussex: John Wiley and Sons;2007.
8. Granas AG, Buajordet M, Stenberg-Nilsen H, Harg P, Horn AM. Pharmacists’ attitudes towards the reporting of suspected adverse drug reactions in Norway. Pharmacoepidem Drug Safe. 2007; 16:429–434.
http://dx.doi.org/10.1002/pds.1298.
Article
9. Tabali M, Jeschke E, Bockelbrink A, Witt CM, Willich SN, Ostermann T, Matthes H. Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine. BMC Public Health. 2009; 9:274.
http://dx.doi.org/10.1186/1471-2458-9-274.
Article